Name: Progress in Catheter Ablation: Clinical Application of New Mapping and Ablation Technology (en Inglés)
SKU: 9164962
Price: 715.12 PEN
Availability: InStock
Author: Liong Bing Liem ; Downar, Eugene
ISBN: 9789048158829

portada Progress in Catheter Ablation: Clinical Application of New Mapping and Ablation Technology (en Inglés)

Progress in Catheter Ablation: Clinical Application of New Mapping and Ablation Technology (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Liong Bing Liem ; Downar, Eugene

Año

2011

Idioma

Inglés

N° páginas

590

Encuadernación

Tapa Blanda

Dimensiones

23.4x15.6x3.1 cm

Peso

0.84 kg.

ISBN

9048158826

ISBN13

9789048158829

Categorías

Medicina preclínica: ciencias básicas
Medicina cardiovascular
Ingeniería: general
Biotecnología

Progress in Catheter Ablation: Clinical Application of New Mapping and Ablation Technology (en Inglés)

Liong Bing Liem ; Downar, Eugene (Autor) · Springer · Tapa Blanda

Libro Nuevo Importado

Envío: 17 a 22 días háb.

S/ 1.589,16S/ 715,12

-55%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

S/ 715,12

Llega entre el 28 Oct y el 05 Nov a CERCADO DE LIMA, Lima. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Progress in Catheter Ablation: Clinical Application of New Mapping and Ablation Technology (en Inglés)"

Catheter ablation is widely accepted as an effective and safe form of therapy for cardiac arrhythmia. In many instances this curative procedure is considered as the first line of therapy if not the ultimate treatment of choice. With the use of radiofrequency (RF) modality; which has revolutionized the technology from a barotraumatic, potentially injurious procedure using high- voltage, direct-current (DC) shock to a safe and relatively painless one; catheter ablation procedure now carries a very low risk and is extremely effective for certain types of arrhythmia. Its efficacy rate in curing supraventricular tachycardia involving an accessory pathway or dual atrioventricular nodal pathways has been near perfect and its application for certain types of atrial and ventricular arrhythmia have also been very satisfactory. However, conventional RF ablation has several well known limitations, most notably is its ability to only produce relatively small, point lesions; rendering it effective only for an arrhythmia with a small and/or a superficial target. It was soon recognized that the technology would not likely to have significant utility in arrhythmia with a more widespread target such as atrial fibrillation or those which involve scarred and deep myocardial tissue such as ventricular tachycardia. Indeed, the application of conventional RF technology in these complex but common arrhythmia has yielded unsatisfactory results.